Biontech Rna Pharmaceuticals GmbH

Biontech Rna Pharmaceuticals GmbH is an SME in Mainz, Germany that has taken part in 2 EU-funded projects since 2013, receiving €1.2M in EU funding.

EU funding received€1.2M
EU projects2
As coordinator0
Running now0
First EU project2013
Latest project2015
CountryGermany
EU registration (PIC)959608488
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biontech Rna Pharmaceuticals GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.1M · 1 project
  • Horizon 2020€93k · 1 project

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • EAVI2020Partner

    European AIDS Vaccine Initiative 2020

    Horizon 2020 · 2015–2022 · Project on CORDIS ↗

    €93ktheir share
  • IACTPartner

    Immunostimulatory Agonist antibodies for Cancer Therapy

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €1.1Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • drug discovery
  • genetics
  • immunisation
  • immunology
  • oncology
  • pandemics
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime